Larson J M, Michalski J P, Collacott E A, Eltorai D, McCombs C C, Madorsky J B
Rheumatol Rehabil. 1981 Nov;20(4):193-7. doi: 10.1093/rheumatology/20.4.193.
The histocompatibility antigen HLA-B27 was determined in 43 patients with post-traumatic spinal cord injury (SCI). The prevalence of B27 was significantly increased in the SCI patients with ectopic ossification. Five of 21 patients with ectopic bone had B27 compared to none of the 22 patients without ossification (P = 0.021). This finding indicates that HLA-B27 is a genetically determined risk factor for the development of heterotopic ossification following injury to the central nervous system. Future studies may determine that HLA-typing can identify a group of patients at a high risk of a disabling complication of SCI who should be treated prophylactically to prevent ectopic bone.
对43例创伤后脊髓损伤(SCI)患者进行了组织相容性抗原HLA - B27检测。在发生异位骨化的SCI患者中,B27的患病率显著升高。21例异位骨患者中有5例为B27阳性,而22例无骨化患者中无一例阳性(P = 0.021)。这一发现表明,HLA - B27是中枢神经系统损伤后异位骨化发生的遗传决定风险因素。未来的研究可能会确定,HLA分型能够识别出一组有发生SCI致残并发症高风险的患者,应对其进行预防性治疗以防止异位骨形成。